摘要:
The present invention is related to a method for the synthesis of ethane-1-hydroxy-1,1-diphosphonic acid or its salt which includes the steps of reacting tetraphosphorus hexaoxide and acetic acid under controlled reaction conditions; hydrolyzing the formed ethane-1-hydroxy-1,1-diphosphonic acid condensates to form ethane-1-hydroxy-1,1-diphosphonic acid; further processing the ethane-1-hydroxy-1,1-diphosphonic acid solution. The process according to the method of the present invention is highly controllable and further is characterized by a high selectivity.
摘要:
A process for the catalyzed electrochemical reduction of carbon dioxide wherein a metal organic framework comprising metal ions and an organic ligand is used as a catalyst and novel metal organic frameworks based on bisphosphonic acids.
摘要:
The present invention concerns conjugate compounds comprising a bisphosphonate covalently bonded to a prostatic acid phosphatase inhibitor and compositions comprising such conjugates. Methods for treating and inhibiting prostate cancer bone metastases, and determining whether a conjugate is useful for such treatment are also provided. In some instances, the bisphosphonate is alendronate, and it is covalently bonded to either tartaric acid or glyceric acid.
摘要:
The disclosure provides, inter alia, novel bisphosphonate compounds and methods of making and using such compounds. In certain embodiments, compounds of the invention include bisphosphonates that are capable of selectively inhibiting one or more of farnesyl diphosphate synthase (FPPS), geranylgeranyl diphosphate synthase (GGPPS), and decaprenyl pyrophosphate synthase (DPPS). In preferred embodiments, compounds of the invention are capable of selectively inhibiting two or more of FPPS, GGPPS, and DPPS. In embodiments, compounds and methods of the invention demonstrate superior activity levels, such as in the anti-cancer context, immunostimulation context, and other contexts, which in several cases exceed the activity levels of previous generation bisphosphonate drugs by orders of magnitude. In embodiments, the invention provides compounds and methods in connection with research and therapeutic applications, e.g., for tumor or cancer cell growth inhibition, activation of gammadelta T cells, inhibition of certain enzymes related to the mevalonate metabolic pathway, bone resorption diseases, cancer, immune disorders, immunotherapy, and infectious diseases.
摘要:
A process for preparing alendronate sodium includes the reaction of gammabutyric acid with phosphorous acid and phosphorus trichioride and subsequent treatment with an aqueous solution of an alkali metal hydroxide, in which the reaction is conducted in liquid ionic solvents.
摘要:
The invention includes pharmaceutically active compounds and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are particularly useful for treatment or prophylaxis of undesired thrombosis.
摘要:
The present invention relates to derivatives of 1-hydroxymethylene-1,1-bisphosphonic acid, the pharmaceutical compositions comprising them, and their application in therapeutics, particularly for the treatment of cancerous tumors. It is also directed to a methods of preparation of such derivatives.
摘要:
The present invention relates to a novel process for making geminal bisphosphonates. The process provides for bisphosphorylation using phosphorus trihalide, phosphorous acid as a reactant/solvent, and a base as an acid acceptor/solvent. The present invention is directed to a process for making geminal bisphosphonates of the general formula: wherein Q is oxygen, —NR4—, sulfur, selenium, or a single bond; m+n is an integer from 0 to about 5, Z is a ring selected from the group consisting of pyridine, pyridazine, pyrimidine, and pyrazine; R1 is hydrogen, substituted or unsubstituted amino, amido, hydroxy, alkoxy, halogen, carboxylate, substituted or unsubstituted alkyl (saturated or unsaturated) having from 1 to about 6 carbon atoms, substituted or unsubstituted aryl, or substituted or unsubstituted benzyl; each R2 is independently, hydrogen, or substituted or unsubstituted alkyl (saturated or unsaturated) having from 1 to about 4 carbon atoms; R3 is one or more substituents selected from the group consisting of hydrogen, substituted or unsubstituted alkyl (saturated or unsaturated) having from 1 to about 6 carbon atoms, substituted and unsubstituted aryl, substituted and unsubstituted benzyl, hydroxy, halogen, carbonyl, alkoxy, nitro, amido, amino, substituted amino, carboxylate, and combinations thereof; R4 is hydrogen, substituted alkyl (saturated or unsaturated) having from 1 to about 4 carbon atoms, or acyl.
摘要翻译:本发明涉及一种制备偕双膦酸盐的新方法。 该方法提供使用三卤化磷,亚磷酸作为反应物/溶剂和碱作为酸受体/溶剂的双磷酸化。 本发明涉及制备以下通式的偕二膦酸盐的方法:其中Q为氧,-NR4-,硫,硒或单键; m + n是0至约5的整数,Z是选自吡啶,哒嗪,嘧啶和吡嗪的环; R 1是氢,取代或未取代的氨基,酰氨基,羟基,烷氧基,卤素,羧酸酯,取代或未取代的具有1至约6个碳原子的烷基(饱和或不饱和的),取代或未取代的芳基或取代或未取代的苄基; 每个R 2独立地为氢,或具有1至约4个碳原子的取代或未取代的烷基(饱和或不饱和的); R3是一个或多个选自氢,取代或未取代的具有1至约6个碳原子的烷基(饱和或不饱和的),取代和未取代的芳基,取代和未取代的苄基,羟基,卤素,羰基,烷氧基, 硝基,酰胺基,氨基,取代的氨基,羧酸酯及其组合; R4是氢,具有1至约4个碳原子的取代烷基(饱和或不饱和的)或酰基。
摘要:
The present invention relates to derivatives of 1-hydroxymethylene-1,1-bisphosphonic acid, the pharmaceutical compositions comprising them, and their application in therapeutics, particularly for the treatment of cancerous tumors. It is also directed to a methods of preparation of such derivatives.
摘要:
A method for treating symptoms, diseases and conditions in extra-reproductive tract tissues that are responsive to treatment with estrogen, using triarylethanes of formula (I) 1 wherein R1 is nullO(CH2)mR3 or null(CH2)nR3; wherein R3 is an anionic substituent; m is an integer from 1 to 4; and n is an integer from 0 to 4; and wherein R2 is either H or nullOH. Each of R1 and R2 can be either meta or para to its respective phenyl ethyl linkage. Compounds having the formula (I) wherein R1 is nullO(CH2)mR3 or null(CH2)nR3; R3 is an anionic substituent; m is 1, 2, 3 or 4; n is 0, 1, 2, 3 or 4; R2is H or nullOH; and wherein each of R1 and R2 is independently meta or para to its respective phenyl ethyl linkage are also provided, with the proviso that R2 is not para nullOH when m is 1 and R3 is nullCOOH.
摘要翻译:使用式(I)的三芳烷(其中R 1为-O(CH 2)m R 3或 - (CH 2)n R 3)治疗对雌激素治疗有反应的外生殖道组织中的症状,疾病和状况的方法。 其中R3是阴离子取代基; m是1至4的整数; 且n为0至4的整数; 并且其中R2是H或-OH。 R1和R2中的每一个可以是其相应的苯基乙基链的间位或对位。 具有式(I)的化合物,其中R 1为-O(CH 2)m R 3或 - (CH 2)n R 3; R3是阴离子取代基; m为1,2,3或4; n为0,1,2,3或4; R2是H或-OH; 并且其中R 1和R 2各自独立地为其各自的苯乙基的间位或对位,条件是当m为1时,R 2不为对位-OH,且R 3为-COOH。